102 related articles for article (PubMed ID: 21474360)
1. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).
Bruttomesso D; Bonomo M; Costa S; Dal Pos M; Di Cianni G; Pellicano F; Vitacolonna E; Dodesini AR; Tonutti L; Lapolla A; Di Benedetto A; Torlone E;
Diabetes Metab; 2011 Nov; 37(5):426-31. PubMed ID: 21474360
[TBL] [Abstract][Full Text] [Related]
2. Maternal-fetal outcomes of pregnant women with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections during pregnancy - A Brazilian health care referral center cohort study.
Ogassavara J; Dualib PM; Mattar R; Dib SA; de Almeida-Pititto B
Arch Endocrinol Metab; 2023 Jun; 67(6):e220483. PubMed ID: 37364140
[TBL] [Abstract][Full Text] [Related]
3. Continuous Subcutaneous Infusion Versus Multiple Daily Injections of Insulin for Pregestational Diabetes in Pregnancy: A Systematic Review and Meta-Analysis.
Fisher SA; Huang J; DuBord AY; Xu NY; Beestrum M; Niznik C; Yeung AM; Nguyen KT; Klonoff DC; Yee LM
J Diabetes Sci Technol; 2023 Sep; 17(5):1337-1363. PubMed ID: 37542367
[TBL] [Abstract][Full Text] [Related]
4. Advances in diabetes management: have pregnancy outcomes in women with type 1 diabetes changed in the last decades?
Citro F; Bianchi C; Nicolì F; Aragona M; Marchetti P; Di Cianni G; Bertolotto A
Diabetes Res Clin Pract; 2023 Nov; 205():110979. PubMed ID: 37890701
[TBL] [Abstract][Full Text] [Related]
5. Perinatal outcomes associated with the use of glargine during pregnancy.
Di Cianni G; Torlone E; Lencioni C; Bonomo M; Di Benedetto A; Napoli A; Vitacolonna E; Mannino D; Lapolla A; ;
Diabet Med; 2008 Aug; 25(8):993-6. PubMed ID: 18959615
[TBL] [Abstract][Full Text] [Related]
6. Congenital malformations among offspring of women with type 1 diabetes who use insulin pumps: a prospective cohort study.
Thorius IH; Husemoen LLN; Nordsborg RB; Alibegovic AC; Gall MA; Petersen J; Mathiesen ER
Diabetologia; 2023 May; 66(5):826-836. PubMed ID: 36640191
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series.
Murphy HR; Kumareswaran K; Elleri D; Allen JM; Caldwell K; Biagioni M; Simmons D; Dunger DB; Nodale M; Wilinska ME; Amiel SA; Hovorka R
Diabetes Care; 2011 Dec; 34(12):2527-9. PubMed ID: 22011408
[TBL] [Abstract][Full Text] [Related]
8. Changes in insulin requirements during pregnancy in Japanese women with type 1 diabetes.
Kambara M; Yanagisawa K; Tanaka S; Suzuki T; Babazono T
Diabetol Int; 2019 Apr; 10(2):102-108. PubMed ID: 31139528
[TBL] [Abstract][Full Text] [Related]
9. Retracted: Effect of Continuous Subcutaneous Injection of Insulin Analogues in Pregnant Women with Diabetes Mellitus Complicated with Ketoacidosis.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9894826. PubMed ID: 37886312
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.
Talaviya PA; Saboo BD; Joshi SR; Padhiyar JN; Chandarana HK; Shah SJ; Vyas CK; Shah AN
Diabetes Metab Syndr; 2013; 7(2):68-71. PubMed ID: 23680243
[TBL] [Abstract][Full Text] [Related]
11. Maternal-Fetal Outcomes in 34 Pregnant Women with Type 1 Diabetes in Sensor-Augmented Insulin Pump Therapy.
Gómez AM; Marín Carrillo LF; Arévalo Correa CM; Muñoz Velandia OM; Rondón Sepúlveda MA; Silva Herrera JL; Henao Carrillo DC
Diabetes Technol Ther; 2017 Jul; 19(7):417-422. PubMed ID: 28731823
[TBL] [Abstract][Full Text] [Related]
12. Multiple daily injections of insulin versus continuous subcutaneous insulin infusion for pregnant women with type 1 diabetes.
Wender-Ozegowska E; Zawiejska A; Ozegowska K; Wroblewska-Seniuk K; Iciek R; Mantaj U; Olejniczak D; Brazert J
Aust N Z J Obstet Gynaecol; 2013 Apr; 53(2):130-5. PubMed ID: 23316799
[TBL] [Abstract][Full Text] [Related]
13. The Successful Immediate Neonatal Transition to Extrauterine Life.
Michel A; Lowe NK
Biol Res Nurs; 2017 May; 19(3):287-294. PubMed ID: 28076969
[TBL] [Abstract][Full Text] [Related]
14. Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996-2010.
Feig DS; Hwee J; Shah BR; Booth GL; Bierman AS; Lipscombe LL
Diabetes Care; 2014 Jun; 37(6):1590-6. PubMed ID: 24705609
[TBL] [Abstract][Full Text] [Related]
15. Continuous subcutaneous insulin infusion versus multiple daily injection therapy in pregnant women with type 1 diabetes.
Gong Y; Wei T; Liu Y; Wang J; Yan J; Yang D; Luo S; Weng J; Zheng X
J Diabetes; 2024 May; 16(5):e13558. PubMed ID: 38664886
[TBL] [Abstract][Full Text] [Related]
16. Insulin Use During Gestational and Pre-existing Diabetes in Pregnancy: A Systematic Review of Study Design.
Castorino K; Osumili B; Lakiang T; Banerjee KK; Goldyn A; Piras de Oliveira C
Diabetes Ther; 2024 May; 15(5):929-1045. PubMed ID: 38494573
[TBL] [Abstract][Full Text] [Related]
17. Advantages of sensor-augmented insulin pump therapy for pregnant women with type 1 diabetes mellitus.
Imafuku H; Tanimura K; Masuko N; Tomimoto M; Shi Y; Uchida A; Deguchi M; Fujioka K; Yamamoto A; Yoshino K; Hirota Y; Ogawa W; Terai Y
J Diabetes Investig; 2023 Dec; 14(12):1383-1390. PubMed ID: 37706627
[TBL] [Abstract][Full Text] [Related]
18. Diabetes and pregnancy study (DAPSY): a 10-year single-center cohort study of pregnancies affected by diabetes.
Kapustin R; Kopteeva E; Tiselko A; Alekseenkova E; Korenevsky A; Shelaeva E; Arzhanova O; Kogan I
Arch Gynecol Obstet; 2024 Jun; 309(6):2643-2651. PubMed ID: 37594491
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
